Gilead Sciences (GILD)
$63.33
0.93 (1.49%)
19:59 EST
GILD Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
82.35B
PE Ratio
24.08
EPS
2.63
Volume (Avg. Vol.)
9.36M
Day's Range
62.13 - 63.60
52-Week Range
56.56 - 85.97
Dividend & Yield
2.23 (3.52%)
GILD Stock Predictions, Articles, and Gilead Sciences News
- From InvestorPlace
- From the Web
5 Undervalued Dividend Stocks to Buy
By
Thomas Niel
With markets at record highs and interest rates at record lows, consider these five dividend stocks to buy for value and yield.
3 Cheap Stocks Worth Buying Right Now
Cheap stocks can come with many caveats. But sometimes, and as these three companies shares point at, they come equipped with some real value.
Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand
As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.
4 Top Biotech Stocks to Buy for Operation Warp Speed
By
Joel Baglole
The U.S. government has pulled out all the stops to develop a treatment for Covid-19. These biotech stocks are leading the race for a cure.
Which Biotech Stocks Are a Buy on Earnings?
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.
4 Top Stock Trades for Monday: TWLO, SNAP, SPAQ, GILD
Twilio, Gilead Sciences, Snap and Spartan Energy Acquisition are our top stock trades to watch on Monday. And here's why.
Gilead Stock: 12 Things for Investors to Know About Remdesivir Approval
Want to know what the big remdesivir approval actually means for Gilead stock? Here's everything investors need to understand.
GILD News: Gilead Stock Pops as FDA Approves Remdesivir Treatment
Gilead stock is climbing higher Thursday after its remdesivir coronavirus treatment received full approval from the FDA. Why it matters.
9 Stocks to Buy for a Wild Ride in November
With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.
7 Highly Rated Pharmaceutical Stocks for Q4
By
Joel Baglole
Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.
10 Undervalued Stocks to Buy
One way to find undervalued stocks is to use free cash flow yield as a barometer. Here are 10 stocks to buy based on this criterion.
7 Biotech Stocks To Buy For Profit From The Vaccine Crunch
As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions.
5 Top Stock Trades for Friday: PINS, CROX, STZ, CAG, GILD
Pinterest, Crocs, Gilead Sciences, Constellation Brands and ConAgra Foods were our top stock trades from Thursday.
Merger Mania: 4 Major Deals to Watch
It’s an exciting time for mergers and acquisitions in some of the hottest sectors -- including software, cloud services, artificial intelligence and health care. Here are four major mergers to watch.
Immunomedics News: IMMU Stock Skyrockets 99% on Gilead Deal
Immunomedics (IMMU) is seeing IMMU stock soar higher Monday following news that it will be acquired by Gilead (GILD) for $21 billion.
5 of the Best Pharmaceutical Stocks to Buy Right Now
A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.
4 Pharmaceutical Stocks With Deep Pipelines
Coronavirus vaccines get all the attention, but these four pharmaceutical stocks benefit from equipment, drug and test kit developments.
What Happened to Gilead Sciences and Is the Stock Still a Buy?
Gilead stock has been under pressure for a few months, giving investors a great risk/reward setup, especially with its coronavirus treatment.
Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally
Strong sales of Gilead's successful novel coronavirus drug, remdesivir, will ultimately lift GILD stock and reward shareholders.
30 Dividend Stocks to Buy Now for 20 Years of Income Growth
With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold